T-group (topology)
7547.1.1 Hypothetical protein TT1679
Ligands and drugs
215
Member domains
129
with ligand contacts (≤ 4 Å)
60.0% of members
128
with DrugDomain annotations
59.5% of members
100
with a DrugBank compound
46.5% of members
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
Chemical profiles are computed for X-groups. 7547.1.1 belongs to X-group 7547 Hypothetical protein TT1679, which has 11 proteins with classified ligands. View its chemical profile →
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB01992 | COA | Coenzyme A | 37 |
| DB12604 | SIS | Sisomicin | 12 |
| DB04729 | LLL | Gentamicin C1a | 10 |
| DB04626 | AM2 | Apramycin | 8 |
| DB00452 | NMY | Framycetin | 7 |
| DB03615 | RIO | Ribostamycin | 4 |
| DB01694 | TAR | D-tartaric acid | 2 |
| DB03419 | URA | Uracil | 2 |
| DB13673 | 9CS | Bekanamycin | 2 |
| DB00684 | TOY | Tobramycin | 1 |
| DB01172 | KAN | Kanamycin | 1 |
| DB01421 | PAR | Paromomycin | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| COA | COENZYME A | 37 |
| ACO | ACETYL COENZYME *A | 29 |
| CL | CHLORIDE ION | 29 |
| MGmetal | MAGNESIUM ION | 16 |
| ZNmetal | ZINC ION | 13 |
| SIS | (1S,2S,3R,4S,6R)-4,6-diamino-3-{[(2S,3R)-3-amino-6-(aminomethyl)-3,4-dihydro-2H-pyran-2-yl]oxy}-2-hydroxycyclohexyl 3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranoside | 12 |
| LLL | (2R,3R,4R,5R)-2-((1S,2S,3R,4S,6R)-4,6-DIAMINO-3-((2R,3R,6S)-3-AMINO-6-(AMINOMETHYL)-TETRAHYDRO-2H-PYRAN-2-YLOXY)-2-HYDROXYCYCLOHEXYLOXY)-5-METHYL-4-(METHYLAMINO)-TETRAHYDRO-2H-PYRAN-3,5-DIOL | 10 |
| AM2 | APRAMYCIN | 8 |
| NMY | NEOMYCIN | 7 |
| 51G | gentamicin C1 | 4 |
| 8I5 | 3N methyl nemycin B | 4 |
| 8I8 | [[(2~{R},3~{S})-5-(6-aminopurin-9-yl)-4-oxidanyl-3-phosphonooxy-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] [(3~{R})-4-[[(3~{S})-3-[2-[(1~{S})-1-[[(1~{S},2~{R},3~{R},4~{S},5~{R})-5-azanyl-3-[(4~{S},5~{R})-4-[(2~{S},3~{R},4~{R},5~{S},6~{E})-3-azanyl-6-(azanylmethylidene)-4,5-bis(oxidanyl)oxan-2-yl]oxy-5-(hydroxymethyl)-3-oxidanyl-oxolan-2-yl]oxy-2-[(2~{S},3~{R},4~{R},5~{S})-3-azanyl-6-(iminomethyl)-4,5-bis(oxidanyl)oxan-2-yl]oxy-4-oxidanyl-cyclohexyl]amino]-1-oxidanyl-ethyl]sulfanylethylamino]-3-oxidanyl-propyl]amino]-2,2-dimethyl-3-oxidanyl-4-oxidanylidene-butyl] hydrogen phosphate | 4 |
| CYT | 6-AMINOPYRIMIDIN-2(1H)-ONE | 4 |
| RIO | RIBOSTAMYCIN | 4 |
| 9CS | (1R,2S,3S,4R,6S)-4,6-DIAMINO-3-[(3-AMINO-3-DEOXY-ALPHA-D-GLUCOPYRANOSYL)OXY]-2-HYDROXYCYCLOHEXYL 2,6-DIAMINO-2,6-DIDEOXY-ALPHA-D-GLUCOPYRANOSIDE | 2 |
| NAmetal | SODIUM ION | 2 |
| TAR | D(-)-TARTARIC ACID | 2 |
| URA | URACIL | 2 |
| CPS | 3-[(3-CHOLAMIDOPROPYL)DIMETHYLAMMONIO]-1-PROPANESULFONATE | 1 |
| DVM | acetylsisomicin | 1 |